Pantazis N, Chini M, Antoniadou A, Sambatakou H, Skoutelis A, Gargalianos P, Kourkounti S, Gogos C, Chrysos G, Psichogiou M, et al. The HIV patient profile in 2013 and 2003: Results from the Greek AMACS cohort. PloS one. 2018;13:e0203601.

Tatsis N, Kakavas S, Metaxas E, Balis E, Tatsis G, Pantazis N, Bakakos P, Koulouris N, Hadjistavrou K. Spirometric Values of Greek People and Comparison with ECSC and GLI Values in COPD People. The open respiratory medicine journal. 2018;12:29.

Rosinska M, Pantazis N, Janiec J, Pharris A, Amato-Gauci AJ, Quinten C, Network AIDSS. Potential adjustment methodology for missing data and reporting delay in the HIV Surveillance System, European Union/European Economic Area, 2015. Eurosurveillance. 2018;23.

Soodla P, Simmons R, Huik K, Pauskar M, Jogeda E-L, Rajasaar H, Kallaste E, Maimets M, Avi R, Murphy G, et al. HIV incidence in the Estonian population in 2013 determined using the HIV-1 limiting antigen avidity assay. HIV medicine. 2018;19:33–41.

Thomadakis C, Meligkotsidou L, Pantazis N, Touloumi G. Longitudinal and Time-to-Drop-out Joint Models Can Lead to Seriously Biased Estimates when the Drop-out Mechanism Is at Random. Biometrics. 2018.

Stirrup OT, Copas AJ, Phillips AN, Gill MJ, Geskus RB, Touloumi G, Young J, Bucher HC, Babiker AG, in EuroCoord CASCADEC, et al. Predictors of CD 4 cell recovery following initiation of antiretroviral therapy among HIV-1 positive patients with well-estimated dates of seroconversion. HIV medicine. 2018;19:184–194.

Papadopoulos A, Ribera A, Mavrogenis A, Rodriguez-Pardo D, Bonnet E, Salles MJ, del Toro MD, Nguyen S, Garcia AB, Skaliczki G, et al. Multidrug (MDR) and extensively drug resistant (XDR) Gram negative prosthetic joint infections (PJI): Role of surgery and impact of colistin administration. International journal of antimicrobial agents. 2018.

Global Trends in CD4 Cell Count at the Start of Antiretroviral Therapy: Collaborative Study of Treatment Programs. Clinical infectious diseases. 2018;66:893–903.